Conducting Clinical Trials Under ICH GCP
September 28-29, 2016
Philadelphia, PA
CRA & CRC: Beginner Program
September 27-29, 2016
San Francisco, CA
Auditing Techniques for Clinical Research Professionals
October 11-12, 2016
San Francisco, CA

Adequate Sponsor Monitoring Systems in Anticipation of FDA Sponsor GCP Inspections January 2012

Jan 13, 2012
Order the DVD of this seminar

Course Description 

In the current regulatory climate, sponsors should anticipate more FDA sponsor GCP inspections and information requests regarding monitoring practices. Many monitoring systems lack components that ensure proper management of the research site without relying on the “star performer.” Monitoring systems should include specific components to ensure control of investigational product, data integrity, oversight of vendors, as well as other areas. The components of a quality monitoring system will be presented so that participants can assess their current practices for identifying gaps and risks, particularly in relation to preparing for regulatory inspections of sponsor monitoring programs.


Learning Objectives 

  • Discuss BIMO sponsor CRO and monitors program
  • Identify components of a sponsor monitoring system: beyond SOPs
  • Distinguish each component’s suggested elements
  • Define adequate oversight of non-employee performers
  • Identify other measures to ensure quality monitoring
  • Evaluate gaps in monitoring systems

Who Should Attend 

  • Sponsor Senior Management
  • Project Managers
  • CRA Managers
  • QA/Compliance
  • CRAs


Elizabeth Ronk Nelson, M.P.H.

Click here for complete trainer biographies 

Course Length Time 

2 hours; 2:00 - 4:00 p.m. Eastern

Hold this course at your company!
For more information, contact Naila Ganatra at (215) 413-2471.